Intellia Therapeutics prices $180 million stock offering at $10.75 per share Apr 29, 2026 07:00AM
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock Apr 29, 2026 07:00AM
Intellia announces $150 million public stock offering Apr 27, 2026 04:01PM
Intellia Announces Proposed Public Offering of Common Stock Apr 27, 2026 04:01PM
Citizens Upgrades Intellia Therapeutics (NTLA) to Market Outperform Oct 6, 2025 02:18AM


Sep 19, 2025 04:40AM Citizens JMP Reiterates Market Perform Rating on Intellia Therapeutics (NTLA)
Aug 7, 2025 07:30AM Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress
Jun 17, 2025 04:07AM Citizens JMP Reiterates Market Perform Rating on Intellia Therapeutics (NTLA)
May 29, 2025 04:08AM Citizens JMP Reiterates Market Perform Rating on Intellia Therapeutics (NTLA)
Feb 27, 2025 03:04PM Intellia Therapeutics (NTLA) PT Raised to $14 at Citi
Jun 3, 2024 06:54AM Citi Reiterates Neutral Rating on Intellia Therapeutics (NTLA)
May 9, 2024 04:40PM Intellia Therapeutics (NTLA) PT Lowered to $29 at Citi
Feb 23, 2024 09:25AM Citi on Intellia Therapeutics (NTLA): 'we believe that NTLA-2001 might find its home as a niche offering'
Oct 18, 2023 09:26AM Intellia Therapeutics (NTLA) Mentioned Positively at Citi, 'We expect shares to open higher Wednesday'
Jun 28, 2021 09:28AM Pre-Open Stock Movers 06/28: (NTLA) (AVXL) (EDIT) Higher; (GTEC) (XPO) (CCL) Lower (more...)
Jun 2, 2020 09:28AM Pre-Open Stock Movers 06/02: (MGI) (WU) (SWBI) Higher; (PUMP) (INVH) (GH) Lower (more...)
Jun 1, 2020 05:30PM After-Hours Stock Movers 6/1: (MGI) (KLDO) (XGN) HIGHER; (PUMP) (INVH) (GH) LOWER (more...)
Aug 27, 2018 08:00AM Intellia Therapeutics to Present at September Healthcare Investor Conferences